Which has the lower trailing P/E, BIO or TMDX?

TMDX has the lower trailing P/E: BIO trades at 55.14 and TMDX at 18.66. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or TMDX?

Over the past five years, TMDX grew revenue faster — BIO at a 0.29% CAGR versus TMDX at 90.79%.

Is BIO or TMDX more profitable?

TMDX runs the higher net margin — BIO at 6.52% versus TMDX at 27.04%.

How have BIO and TMDX total returns compared?

Over the past 5 years, BIO delivered 8.67% and TMDX delivered 23.91% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs TransMedics Group, Inc. (TMDX)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 4, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$8.99B

$332.55HealthcareDelayed quote: Aug 4, 2026, 12:49 PM EDT

TMDX

TransMedics Group, Inc.

$2.80B

$81.00HealthcareDelayed quote: Aug 4, 2026, 12:50 PM EDT

Total return — BIO vs TMDX

growth of $100 · dividends reinvested · last 7y

BIO +10.8%TMDX +264.7%TMDX compounded faster

BIO TMDX

BIO vs TMDX: by the numbers

•BIO is the larger company ($8.99B vs $2.80B market cap).
•TMDX trades at the lower trailing earnings multiple (18.66 vs 55.14 P/E), one valuation lens rather than an overall verdict.
•TMDX converts more revenue to profit (27.04% vs 6.52% net margin).
•TMDX grew revenue faster over the past five years (90.79% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	TMDX
P/E ratio	55.14	18.66
Forward P/E	37.02	44.58
P/S ratio	3.48	4.64
P/B ratio	1.32	5.97
PEG ratio	N/A	0.05
EV / EBITDA	22.61	26.33
FCF yield	3.96%	5.13%

Profitability

Metric	BIO	TMDX
Gross margin	51.87%	59.09%
Operating margin	9.25%	14.85%
Net margin	6.52%	27.04%
ROE	2.46%	34.80%
ROIC	2.04%	10.94%

Growth (annualized)

Metric	BIO	TMDX
Revenue CAGR (5Y)	0.29%	90.79%
EPS CAGR (5Y)	-26.27%	N/A
FCF CAGR (5Y)	-7.57%	N/A
Total return CAGR (5Y)	-14.81%	23.91%

Frequently asked

Which has the lower trailing P/E, BIO or TMDX?: TMDX has the lower trailing P/E: BIO trades at 55.14 and TMDX at 18.66. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or TMDX?: Over the past five years, TMDX grew revenue faster — BIO at a 0.29% CAGR versus TMDX at 90.79%.
Is BIO or TMDX more profitable?: TMDX runs the higher net margin — BIO at 6.52% versus TMDX at 27.04%.
How have BIO and TMDX total returns compared?: Over the past 5 years, BIO delivered 8.67% and TMDX delivered 23.91% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full TMDX analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio TransMedics P/E ratio Bio-Rad Laboratories dividend yield TransMedics dividend yield Bio-Rad Laboratories ROE TransMedics ROE Bio-Rad Laboratories operating margin TransMedics operating margin Bio-Rad Laboratories revenue growth TransMedics revenue growth Bio-Rad Laboratories free cash flow TransMedics free cash flow

Bio-Rad Laboratories & TransMedics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 4, 2026.